Light Mode
$0.1138 ↑ +0.0000 (+0.00%) Trading Up from the previous close of $0.1138, $0.0053 below the day’s high of $0.1191
-0.69 (-85.90%) / 6M
Momentum, market sentiment, and recent alerts
VVOS reads poor: price sits below both the 20- and 200-day averages, the 12-month move is -95.4%.
No alerts for VVOS in the last day.
Earnings, valuation, and balance sheet
Company profile and competitor comparison
Vivos Therapeutics, Inc. is a medical technology company which engages in the development and commercialization of treatment alternatives for patients with sleep disordered breathing (SDB). Its solutions are also offered for patients with mild-to-moderate obstructive sleep apnea (OSA). The company was founded by Gurdev Dave Singh, Susan McCullough, RaeAnn Byrnes, Todd Huntsman, and R. Kirk Huntsman on July 7, 2016 and is headquartered in Littleton, CO.
Real-time scanning and AI-generated signals across the entire market.
Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.